Cargando…
HEMOLYTIC ANEMIA AND METHEMOGLOBINEMIA DUE TO HYDROXYCHLOROQUINE USE FOR COVID-19 TREATMENT IN A GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT PATIENT
Autores principales: | Lim, Steven, Bhatia, Karishma, Lee, Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548775/ http://dx.doi.org/10.1016/j.chest.2020.08.527 |
Ejemplares similares
-
Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19
por: Laslett, Nicole, et al.
Publicado: (2021) -
COVID-19-ASSOCIATED DIRECT ANTIGLOBULIN TEST-NEGATIVE WARM AUTOIMMUNE HEMOLYTIC ANEMIA
por: HSIEH, TIEN-CHAN, et al.
Publicado: (2021) -
HEMOLYTIC ANEMIA EXACERBATION IN CHRONIC PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AFTER COVID-19 VACCINATION
por: YOU, JOSEPH, et al.
Publicado: (2022) -
DISSEMINATED INTRAVASCULAR COAGULOPATHY FROM WARM AUTOIMMUNE HEMOLYTIC ANEMIA IN A PATIENT WITH COVID-19
por: Damani, Jalal
Publicado: (2020) -
Hemolytic Anemia due to Glucose 6 Phosphate Dehydrogenase Deficiency Triggered by Type 1 Diabetes Mellitus
por: Orman, Burçe, et al.
Publicado: (2023)